Suppr超能文献

[给非生长激素缺乏的矮小女童注射生长激素:性腺和子宫的超声表现]

[Growth hormone administered to non-growth hormone deficient, small girls: echographic aspect of the gonads and uterus].

作者信息

Colle M, Broussin B

机构信息

Centre d'Explorations Endocriniennes Pédiatriques, Bordeaux.

出版信息

Ann Pediatr (Paris). 1993 Sep;40(7):426-31.

PMID:8239393
Abstract

The effect of growth hormone (GH) treatment on prepubertal gonads is controversial especially with regard to the risk of precocious puberty. Ultrasound assessment of ovarian volume, follicle size, and uterine growth was performed in 20 premenarcheal girls (8.0 +/- 2.6 years) receiving growth hormone (GH) for short stature (-2.8 +/- 0.4 SD) not related to growth hormone deficiency or Turner syndrome. Mean GH dosage was 1.0 +/- 0.4 IU/kg/week and mean duration of treatment at evaluation was 16.3 +/- 8.9 months. All patients underwent real time ultrasonography of the pelvic organs and ten subjects also had color Doppler studies of the ovarian and uterine arteries. Ultrasound findings were similar to those reported in normal prepubertal girls. Mean uterine length (29.1 +/- 7.5 mm) and volume (1.23 +/- 0.86 ml) were correlated with age but not with dosage or duration of GH treatment. Ovarian volumes was within the normal age-specific range in all patients except a 7.9 year old girl with substantially enlarged ovaries (4.7 ml) but no evidence or precocious puberty. Ovarian follicles were found in five girls; they measured less than 9 mm in diameter in every case except one (13 mm follicle in an 11-year-old). Blood flow in the ovarian arteries was seen on 5 of the 10 color Doppler studies and was not correlated with dosage or duration of GH treatment. Administration of GH to non-GH-deficient girls did not substantially affect the internal genital organs. It remains uncertain whether the single case of ovarian enlargement seen was related to GH treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

生长激素(GH)治疗对青春期前性腺的影响存在争议,尤其是在性早熟风险方面。对20名初潮前女孩(8.0±2.6岁)进行了超声评估,这些女孩因身材矮小(-2.8±0.4标准差)接受生长激素(GH)治疗,其身材矮小与生长激素缺乏或特纳综合征无关。平均GH剂量为1.0±0.4国际单位/千克/周,评估时的平均治疗持续时间为16.3±8.9个月。所有患者均接受了盆腔器官实时超声检查,10名受试者还对卵巢和子宫动脉进行了彩色多普勒研究。超声检查结果与正常青春期前女孩的报道相似。平均子宫长度(29.1±7.5毫米)和体积(1.23±0.86毫升)与年龄相关,但与GH治疗的剂量或持续时间无关。除一名7.9岁卵巢明显增大(4.7毫升)但无性早熟证据的女孩外,所有患者的卵巢体积均在正常年龄范围内。在5名女孩中发现了卵巢卵泡;除一例(一名11岁女孩有一个13毫米的卵泡)外,其他病例的卵泡直径均小于9毫米。10例彩色多普勒研究中有5例观察到卵巢动脉血流,且与GH治疗的剂量或持续时间无关。对非生长激素缺乏的女孩使用GH并未对其内生殖器产生实质性影响。所观察到的单例卵巢增大是否与GH治疗有关仍不确定。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验